Background The incidence of cancer is increasing globally, and a greater number of patients
will receive treatments though central vascular access devices (CVADs). Only a few …

Background Patients with cancer can expect to receive numerous invasive vascular access
procedures for intravenous therapy and clinical diagnostics. Due to the increased incidence …

Introduction: Venous access is a crucial element in chemotherapy delivery. It remains
unclear whether cancer patients prefer a port to a peripherally inserted central catheter …

Background Optimal selection of vascular access devices is based on multiple factors and is
the first strategy to reduce vascular access device‐related complications. This process is …

Background Peripherally inserted central catheters (PICCs) and new type of arm-port, the
PICC-port, are currently used for neoadjuvant chemotherapy treatment in patients with …

Objectives Peripherally inserted central catheters are commonly used in cancer patients and
provide vascular access for the administration of chemotherapy, antibiotics, or parenteral …

Background: The presence of totally implantable venous access devices (TIVADs), as any
permanent or semipermanent medical devices, has an impact on the quality of life (QoL) of …

[目的] 编制应用植入式上臂输液港病人的自我管理行为量表并验证其信效度.[方法]
通过文献回顾以及半结构访谈拟定应用植入式上臂输液港病人自我管理行为量表初始条目池 …

Aim The aim of this study was to explore the experiences of cancer patients regarding
venous access ports. Background The utilization of intravenous access ports for …

Totally implanted venous access ports (TIVAPs) have been established as effective and safe
devices for oncologic patients. In breast cancer setting, the implant of the reservoir at mid …